Genetic or epigenetic inactivation of the pathway formed by the Fanconi anemia (FA) and BRCA1 proteins occurs in several cancer types, making the affected tumors potentially hypersensitive to DNA cross-linkers and other chemotherapeutic agents. It has been proposed that the inability of FA/BRCA-defective cells to form subnuclear foci of effector proteins, such as FANCD2, can be used as a biomarker to aid individualization of chemotherapy. We show that FANCD2 inactivation not only renders cells sensitive to cross-links, but also oxidative stress, a common effect of cancer therapeutics. Oxidative stress sensitivity does not correlate with FANCD2 or RAD51 foci formation, but associates with increased γH2AX foci levels and apoptosis. Therefore, FANCD2 may protect cells against cross-links and oxidative stress through distinct mechanisms, consistent with the growing notion that the pathway is not linear. Our data emphasize the need for multiple biomarkers, such as γH2AX, FANCD2, and RAD51, to capture all pathway activities.
1. Introduction
Fanconi anemia (FA) is a heterogeneous clinical syndrome characterized by bone marrow failure,
congenital defects, and cancer predisposition [1–5]. Cells derived from FA patients exhibit multiple abnormalities including chromosomal instability and hypersensitivity to genotoxic agents, particularly drugs that cause DNA interstrand cross-links (ICLs), such as mitomycin C (MMC). FA is caused by mutations in any of the known 13 FANC genes, FANCA through FANCN
[2, 5–7]. The FANC proteins together
with BRCA1 cooperate in a common biochemical pathway, the FA/BRCA pathway,
which is believed to function mainly in the detection, stabilization, and
repair of stalled DNA replication forks [2, 4]. A multiprotein nuclear core
complex is required for baseline and damage-induced monoubiquitination of the
downstream effectors FANCD2 and FANCI [7]. In response to DNA damage
such as replication fork-blocking ICLs, monoubiquitinated FANCD2 relocates into
chromatin and colocalizes with BRCA2/FANCD1, RAD51, and other DNA damage
response proteins; and these protein accumulations can be visualized as
subnuclear foci [8–13]. Disruption of the nuclear core complex or mutation of FANCD2's monoubiquitination site at K561 impairs repair processes, including homologous recombination, that are active at stalled forks [8, 14]. These repair defects cause chromosomal aberrations, particularly chromatid-type breaks and exchanges, and
cell death following ICL induction.
Inactivation of the FA/BRCA pathway
by genetic or epigenetic mechanisms, which are frequently found in cancer, can
be detected by the inability of the affected cells to form FANCD2 foci in response
to DNA damage [15, 16]. There is currently great
interest in using FANCD2 foci formation as a functional biomarker to predict
the sensitivity of cancer cells to cross-linking drugs such as cisplatin [16].
In addition to ICL hypersensitivity,
it has been proposed that FA cells suffer from a prooxidant state that is associated with overproduction or impaired detoxification of reactive oxygen species [17]. Cells with defects in the FA pathway may demonstrate increased apoptosis, hypersensitivity to oxygen, excessive oxidative DNA damage after treatment with hydrogen peroxide (H2O2),
improved growth when maintained at low oxygen tension, or reduction of
chromosomal aberrations after treatment with antioxidants [18–21]. At least for FANCC, molecular mechanisms have been identified that support a role in redox
metabolism and apoptosis [22–24]. Mutational analysis
dissociated FANCC's participation in apoptotic signaling pathways from its role
in the response to MMC [25]. Other FA proteins for which
an involvement in oxidative stress responses have been reported include FANCG,
which not only participates in redox-regulated nuclear complex formation [26], but also locates to
mitochondria where it interacts with peroxidase to prevent oxidative
stress-induced apoptosis [27].
Importantly,
the oxidative stress sensitivity caused by FA/BRCA defects likely results in or
contributes to cellular chemosensitivity for various agents [28]. However, it is unknown
whether this sensitivity can be detected by abrogated FANCD2 or RAD51 foci formation. Here, we use a human model cell line to describe a dual function of FANCD2 that protects against ICLs and oxidative damage through distinct mechanisms, which cannot be encompassed by a single protein biomarker.
2. Material and Methods2.1. Cell Lines
SV40-transformed
fibroblasts derived from patients with FA group D2 (PD20 cells) or A (PD220)
and their retrovirally complemented counterparts expressing wild-type protein
were obtained from the OHSU
Fanconi anemia cell repository [29]. Cells were maintained in αMEM with 2 mM glutamine and 15% fetal
bovine serum (Sigma-Aldrich, Saint Louis, USA).
All cell lines tested free of mycoplasma.
2.2. Cytotoxicity Assays
Exponentially growing cells were incubated with 0–50 μM H2O2 at room temperature for 2 hours or 0–0.5 μg/mL MMC for 1 hour (both Sigma-Aldrich). Cells were plated for colony formation and stained after 14 days with methylene blue.
Apoptosis was measured 24–48 hours after
treatment. For scoring of apoptotic nuclei, cells were stained with DAPI (10 μg/mL). 500 nuclei per sample were examined with a fluorescence microscope (Olympus BX51) and assessed for cell morphology and apoptotic bodies. For detection of the sub-G1 DNA fraction, cells were stained with 0.1 mg/mL PI,
containing 0.5 mg/mL RNase and 0.1% NP40 detergent, and assayed by flow cytometry (FACSCalibur, Becton Dickinson, Franklin Lakes, USA). 30,000 cells
were analyzed using CellQuest software. Sub-G1 populations were determined by histogram gating.
2.3. Detection of Subnuclear Protein Foci
Cells were seeded in chamber slides or onto cover
slides and treated with H2O2 (25 μM) or MMC
(0.25 μg/mL). After 0.5–5 hours, cells
were fixed for 15 minutes with 4% paraformaldehyde at room temperature and permeabilized for 10 minutes with 0.5% Triton X-100 (Sigma-Aldrich) in phosphate-buffered saline. Following blocking with 10% serum for 1 hour at room temperature, cells were incubated for 2 hours at 37°C with anti-γ-H2AX (1 : 100 dilution, #4411-PC-100 from
Trevigen, Gaithersburg, USA), anti-Rad51 (1 : 200, Ab-1 from Calbiochem, EMD Chemicals, San Diego, USA), or anti-FANCD2 (1 : 400,
NB100-182 from Novus, Novus Biological, Colorado, USA) antibody. This was followed by incubation with
species-specific fluorescein- or Alexa-488-conjugated secondary antibody (Pierce #31583 or Molecular Probes #A-21441). All slides were counterstained with DAPI
and visualized by fluorescence microscopy. Only cells with nuclei containing more than five foci were scored. At least 300 nuclei were examined for each data point.
2.4. Cell Cycle Analysis
Cell cycle distributions with and without
H2O2 treatment (25 μM for 2 hours) were assessed using PI staining. To measure DNA
synthesis after treatment with H2O2
or ionizing radiation (IR) (Siemens Stabilipan 2
X-ray generator, 250 KVp, Siemens Medical Systems, Malvern, USA), cells were pulse labeled with 100 μM (+)-5-bromo-2′-deoxyuridine (BrdU, Sigma Aldrich) for 30 minutes at 37°C, blocked with 0.5% Tween 20, and incubated with anti-BrdU antibody
(Becton Dickinson) for 1 hour at 37°C Subsequently, cells were incubated with FITC-conjugated rabbit antimouse antibody (Dako, Carpinteria, USA) at 37°C for 45 minutes. BrdU-positive nuclei were scored using fluorescence microscopy and at least 300 nuclei were counted for each data point.
2.5. Cytogenetic Studies
Analysis of chromosomal damage was performed as described [30]. Lethal G1 aberrations were scored
including terminal and interstitial deletions as well as dicentric chromosomes. For G2 aberrations, chromatid-type aberrations such as chromatid fragments, isochromatid fragments, translocations as well as tri- and quadriradials were expressed as breaks per cell.
3. Results3.1. FANCD2 Foci Only Partially Reflect Protein Function
The ability of the FA pathway to remove replication fork blocking ICLs is dependent upon intact FANCD2 function. Mutation of FANCD2 in immortalized human fibroblasts
obtained from a patient with FA group D2 (PD20) leads to ICL sensitivity
(Figure 1(a)) and abrogated FANCD2 foci formation (not shown), while the
wild-type complemented derivative cell line (PD20-wtD2) was normal in this
regard. Accumulating evidence also links components of the FA pathway to the
cellular response to oxidative stress [1, 17, 31, 32], but whether this process
depends on foci formation as well was unknown. To address this question, cells
were exposed to low concentrations of H2O2, which do not
cause measurable DNA double-strand breaks (DSBs). We discovered that PD20 cells
were significantly more sensitive to H2O2 than the
PD20-wtD2 cells expressing wild-type FANCD2 (Figure 1(b)), which has not been
described previously. Surprisingly, while H2O2 was a potent inducer of FANCD2 foci in cells with a functional FA pathway (Figure 2(a)), FANCA-mutant PD220 fibroblasts were not hypersensitive to H2O2 despite an inability of these cells to form FANCD2 foci (Figure 2(b)). This
suggested that the aspect of FANCD2 function that depends on foci formation is
not required for mediating resistance to oxidative DNA damage.
Hypersensitivity of FANCD2-deficient
human fibroblasts to DNA damage. (a) Clonogenic survival of cells with or without wild-type FANCD2 (PD20-wtD2 or PD20, resp.) after treatment with varying concentrations of MMC for one hour. (b) Analogously, clonogenic survival after exposure to hydrogen peroxide
(H2O2) for two hours. Data represent logarithmic means +/− standard error based on four independent repeats.
Resistance of FANCA-mutant cells with defective FANCD2 function to hydrogen peroxide (H2O2).
(a) Representative images illustrating staining for subnuclear FANCD2 foci in isogenic fibroblast pairs, either deficient for FANCD2 (PD20) or FANCA (PD220) and their respective wild-type (wt) complemented counterparts. Foci were visualized three hours after treatment with
H2O2 (25 μM for 2 hours). (b) Clonogenic survival of cells with or without wild-type FANCA after treatment with varying concentrations of H2O2. Data
represent logarithmic means +/− standard error from 15-repeat experiments.
3.2. FANCD2 Mediates Resistance to Oxidative Damage Independently of Its Function in
the Replication-Associated DNA Damage Response
RAD51 subnuclear foci are thought to reflect sites of homologous recombination, which is
required for the repair and restart of stalled replication forks [2]. Accordingly, PD20 cells,
which are hypersensitive to the cross-linker MMC, were unable to mount an RAD51
foci response following MMC exposure (Figures 3(a) and 3(b)). In contrast, PD20
cells were clearly able to form RAD51 foci in response to H2O2, which was comparable to the foci formation seen in PD20-wtD2 cells exposed to the same
H2O2 concentration. Next, we asked whether the
oxidative damage-induced S-phase checkpoint also remained intact in PD20 cells. As reported previously [33], PD20 cells continued to
incorporate BrdU following IR, indicating a defective S-phase checkpoint
(radioresistant DNA synthesis) (Figure 3(c)). However, in response to H2O2,
PD20 cells demonstrated a decrease in DNA synthesis indicating intact
checkpoint function in response to oxidative damage. We also analyzed cell
cycle distributions in response to H2O2
(Figure 3(d)) or IR (data not shown) to ensure that our observations were not biased by major
imbalances in the position of cells in the cell cycle. We found that the cell cycle profiles of PD20 and PD20-wtD2 cells, treated or untreated, were almost identical.
Normal DNA damage responses in FANCD2-deficient cells treated with hydrogen peroxide (H2O2). (a) Illustration of RAD51 foci formation in PD20 and PD20-wtD2 cells 5 hours after exposure to MMC (0.25 μg/mL for 1 hour) or
H2O2 (25 μM for 2 hours). (b) Induction of RAD51 foci formation above background levels by MMC or H2O2. Because equal drug concentrations were used, rather than isoeffective concentrations with regard to cell survival, the extent of foci induction between FANCD-deficient and -complemented cells is not directly comparable. Data represent means with upper
standard error based on three independent repeats. (c) DNA synthesis measured by BrdU pulse labeling in cells treated with ionizing radiation (IR, 8 Gy) or H2O2 (25 μM). Data represent means with upper standard error based on two
independent experiments. (d) Cell cycle distribution of propidium-iodide cell populations by flow cytometry. A representative experiment is shown. Percentages of cells in the G1, S, and G2 (and M) phases of the cell cycle are indicated.
3.3. Increased Cytotoxicity in H2O2-Treated PD20 Cells is not Associated with Induced Chromosomal Aberrations but Increased Apoptosis
Activation of
the S-phase checkpoint by H2O2 (Figure 3(c)) suggested
the presence of damaged DNA. We therefore studied γH2AX foci, which are typically used as markers of DSBs, but may also reflect stalled replication forks or oxidative damage [34, 35]. We discovered a substantial
increase in the formation of γH2AX foci in PD20, but not PD20-wtD2
cells (Figures 4(a) and 4(b)). Next, we asked whether the increase in DNA
damage as marked by γH2AX foci led to the occurrence of
chromosomal aberrations in H2O2-treated PD20 cells. Treatment of FA cells with cross-linkers such as MMC or diepoxybutane generally results in a markedly
elevated frequency of chromatid-type aberrations likely due to a failure to maintain and repair replication forks stalling at interstrand cross-links [2, 4] Typical radial structures are found in more than 20% of cells and the number of breaks per cell may range from 1 to 20 [3, 36]. In contrast, exposure of PD20 cells to H2O2 did not induce any radial formation up to a concentration of 40 μM of H2O2 despite the significant difference in clonogenic survival at doses up to 25 μM. We only recorded a mild increase in chromatid aberrations up to 0.5 break per cell at 50 μM of H2O2 (Figure 4(c)), which is clearly
distinct from the hallmark chromosomal instability seen with cross-linkers yet consistent with the normal RAD51 and S-phase checkpoint responses to H2O2 (Figure 3). The observed lack of significant chromosomal instability in
response to H2O2 is also consistent with previous
observations [37]. To identify the mechanism of cell death, we turned our attention to apoptosis endpoints. Using two different assays, we found that H2O2-treated
PD20 cells exhibited elevated levels of apoptosis compared to the wild-type
complemented cells (Figure 4(d)). In contrast, MMC treatment does not typically
induce increased apoptosis in FANC-deficient cells [38, 39]. Altogether, our data suggest
that the mode of cell death following oxidative damage is not related to
chromosomal aberrations that may arise due to failed repair of stalled
replication forks.
DNA damage and cell survival
as a function of FANCD2 status. (a) Representative images of the formation of γH2AX foci in PD20 versus wild-type
complemented cells 30 minutes after completion of H2O2 treatment. (b) Quantification of γH2AX foci response. Data represent means with upper standard error based on two independent experiments. (c) G2-type chromosomal aberrations are expressed as breaks per cell as a function of increasing H2O2 concentration in FANCD2-deficient and
wild-type complemented PD20 cells. Data represent means with SEM based on at least three repeat experiments. (d) Apoptosis induction by
H2O2 (50 μM) in cells with or without wild-type FANCD2 using fluorescence microscopy to assess apoptotic morphology by DAPI staining and flow cytometric analysis for sub-G1 DNA content. Representative experiments based on the
apoptotic response at 24 hours are shown (similar results were obtained at 48 hours and with 25 μM H2O2).
4. Discussion
The formation of
subnuclear FANCD2 foci in response to damaged DNA has been regarded as a
functional biomarker for the activity of the FA pathway [16, 40]. Here, we report for the
first time that the ability of cells to form FANCD2 foci only partially
reflects the activity of the FANCD2-dependent cytotoxic stress response.
Specifically, FANCA-mutant cells were not found to be sensitive to DNA damage caused by H2O2 despite an inability to form FANCD2 foci (Figure 2). In addition, we found that the MMC hypersensitivity, but not the H2O2 hypersensitivity, of FANCD2-deficient fibroblasts was associated with an
abrogation of RAD51 foci formation (Figure 3) [38], suggesting different cellular responses to the two agents. Of note, previous data on the ability of FA cells
to form damage-induced RAD51 foci have been somewhat inconsistent, possibly a
reflection of the cell type under study and the particular assay conditions [9–13]. Together, our data suggest
that neither FANCD2 nor RAD51 foci formation adequately captures all activities of this pathway.
The mechanisms underlying the ICL and oxidative stress hypersensitivity of FA cells have been controversial [17, 41]. The susceptibility to oxidative stress has long been recognized as a general and uniform phenotype of primary cells from FA patients, while cross-linker sensitivity appears to be variable across complementation groups [1, 17, 21]. Saito et al. [21] found that the oxygen
hypersensitivity of primary human fibroblast cultures was lost upon
transformation with SV40 large T-Antigen, but the MMC hypersensitivity
remained. It was thus argued that oxygen hypersensitivity represents a
“secondary” defect of FA cells. Yet, our data indicate that SV40-transformed FANCD2-deficient PD20 fibroblasts have retained their susceptibility to oxygen
(assuming that oxygen and H2O2 hypersensitivity are correlated). It is conceivable that differences in cell culture conditions used for establishing PD20 cells versus the cell lines reported by Saito et al. have had a differential impact on oxygen sensitivities. Alternatively, FANCD2 may play a more important role in the response to oxidative stress than other FA proteins such as FANCA. We acknowledge that because our cells are SV40-transformed, the p53
response is compromised; which could affect apoptosis, cell cycle profiles, and chromosomal aberrations. It will therefore be important to expand our findings to primary cell cultures.
The ICL resistance of cells is dependent upon the integrity of the nuclear FANC
core complex, monoubiquitination, and subsequent chromatin localization of FANCD2 [8]. However, this model of the
pathway appears to be incomplete. For example, a phosphomutant of FANCE
restored FANCD2 monoubiquitination but not cross-linker sensitivity of
FANCE-deficient lymphoblasts [42], and in a chicken cell system
components of the FANC core complex mediated cross-linker resistance partly
independent of FANCD2 monoubiquitination and chromatin targeting [43]. These observations suggest
that the FANC core complex targets additional proteins required for cross-linker
resistance and that nonubiquitinated FANCD2 may possess additional cellular
functions. The latter notion is supported by the more severe phenotype of
FANCD2−/− mice compared to FANCA or FANCC knockouts [10]. Part of the phenotype of
FANCD2-deficient cells may also reflect an impaired function of FANCI, which
forms a complex with FANCD2 [7].
We
favor the view that FANC proteins are multifunctional proteins that form
different subcomplexes with specific functions [1, 44]. In particular, FANCD2
appears to have a dual role in distinct cellular pathways that respond to replication fork damage and oxidative stress. Alternatively, the mechanisms
underlying the observed H2O2 and ICL toxicity in FA cells may be overlapping, as discussed by Pagano et al. [28].
Of
note, the observation that H2O2 induces the formation of FANCD2 foci (Figure 2) [41], which presumably locate to
replication forks, is consistent with a dual model of function: various
genotoxic stresses, including H2O2, hydroxyurea, or UV
radiation, interfere with replication and thereby recruit FANCD2 to replication
forks. However, only some types of DNA damage such as ICLs are severe enough to
subsequently require the repair-promoting function of monoubiquitinated FANCD2,
while cells exposed to UV or H2O2 do not appear to depend on this mechanism for their survival [11].
What
are the molecular mechanisms by which FANCD2 protects against oxidative stress
and apoptosis? Several interactions of FANCC with prosurvival and redox
pathways have been reported [1, 22–24] and it is likely that FANCD2
possesses similar properties. Increased levels of γH2AX in FANCD2-deficient cells (Figure 4(b))
are consistent with an impaired ability to protect the DNA against reactive oxygen species, although we note that γH2AX foci may also reflect apoptosis, senescence, or
changes in chromatin conformation that do not necessarily reflect DNA strand
breakage [34, 45, 46]. The former is relevant to our observation that these cells may also be more prone to undergo apoptosis in
the presence of high levels of oxidative DNA damage (Figure 4(d)). Interestingly,
in a recent review article it has been hypothesized that H2O2 induces the formation of a complex containing FANCD2, FANCC, and STAT5 [1]. The complex may be required for optimal phosphorylation of STAT proteins, which function as nuclear transcription factors to promote cell survival.
In conclusion, the FA/BRCA pathway appears increasingly multifunctional and
heterogeneous. Elucidating the precise roles of FANCD2 and other pathway
members in the response to diverse cytotoxic stresses will be important for a better understanding of the chemosensitivity of cancers, which frequently harbor defects in this pathway. Multiple predictive biomarkers, including γH2AX, FANCD2, and RAD51 foci, are
required for accurately identifying pre-existing FA/BRCA defects in tumors and
thus aiding individualization of therapy.
Acknowledgments
This work was supported in part by a grant from the Susan G. Komen for The Cure Breast Cancer Foundation to LAK, by NIH Grant no. P01 CA095227 to KDH, and by a grant from the Roggenbuck Foundation,
Germany, to KB. The excellent technical assistance of Ms. Agnieszka Wrona is acknowledged.
BagbyG. C.grover@ohsu.eduAlterB. P.Fanconi anemia2006433147156KennedyR. D.D'AndreaA. D.alan_dandrea@dfci.harvard.eduThe Fanconi anemia/BRCA pathway: new faces in the crowd200519242925294010.1101/gad.1370505JoenjeH.H.Joenje.HumGen@med.vu.nlPatelK. J.The emerging genetic and molecular basis of Fanconi anaemia20012644645710.1038/35076590NiedernhoferL. J.LalaiA. S.HoeijmakersJ. H. J.j.hoeijmakers@erasmusmc.nlFanconi anemia (cross)linked to DNA repair200512371191119810.1016/j.cell.2005.12.009WangW.wangw@grc.nia.nih.govEmergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins200781073574810.1038/nrg2159PatelK. J.kjp@mrc-lmb.cam.ac.ukFanconi anemia and breast cancer susceptibility200739214214310.1038/ng0207-142SmogorzewskaA.MatsuokaS.VinciguerraP.Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair2007129228930110.1016/j.cell.2007.03.009Garcia-HigueraI.TaniguchiT.GanesanS.Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway20017224926210.1016/S1097-2765(01)00173-3GodthelpB. C.WiegantW. W.WaisfiszQ.Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi
anemia complementation groups from D1/BRCA220065941-2394810.1016/j.mrfmmm.2005.07.008HoughtalingS.houghtal@ohsu.eduTimmersC.NollM.Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice200317162021203510.1101/gad.1103403TebbsR. S.HinzJ. M.YamadaN. A.New insights into the Fanconi anemia pathway from an isogenic FancG
hamster CHO mutant200541112210.1016/j.dnarep.2004.06.013WangX.AndreassenP. R.D'AndreaA. D.alan_dandrea@dfci.harvard.eduFunctional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin200424135850586210.1128/MCB.24.13.5850-5862.2004DigweedM.martin.digweed@charite.deRotheS.DemuthI.Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia20022371121112610.1093/carcin/23.7.1121NakanishiK.YangY.-G.PierceA. J.Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair200510241110111510.1073/pnas.0407796102LyakhovichA.SurrallesJ.jordi.surralles@uab.esDisruption of the Fanconi anemia/BRCA pathway in sporadic cancer200623219910610.1016/j.canlet.2005.07.038KennedyR. D.D'AndreaA. D.alan_dandrea@dfci.harvard.eduDNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes200624233799380810.1200/JCO.2005.05.4171PaganoG.gbpagano@tin.itYoussoufianH.Fanconi anaemia proteins: major roles in cell protection against oxidative damage200325658959510.1002/bies.10283TakeuchiT.MorimotoK.Increased formation of 8-hydroxydeoxyguanosine, an oxidative DNA damage, in lymphoblasts from Fanconi's anemia patients due to possible catalase deficiency19931461115112010.1093/carcin/14.6.1115JoenjeH.ArwertF.ErikssonA. W.de KoningH.OostraA. B.Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia1981290580214214310.1038/290142a0DallapicolaB.PorfirioB.MokiniV.AlimenaG.IsacchiG.GandiniE.Effect of oxidants and antioxidants on chromosomal breakage in Fanconi anemia lymphocytes1985691626510.1007/BF00295530SaitoH.HammondA. T.MosesR. E.Hypersensitivity to oxygen is a uniform and secondary defect in Fanconi anemia cells1993294325526210.1016/0921-8777(93)90008-5CummingR. C.LightfootJ.BeardK.YoussoufianH.O'brienP. J.BuchwaldM.Fanconi anemia group C protein prevents apoptosis in hematopoietic cells
through redox regulation of GSTP120017781482010.1038/89937FagerlieS. R.sfagerli@fhcrc.orgKoretskyT.Torok-StorbB.BagbyG. C.Impaired type I IFN-induced Jak/STAT signaling in FA-C cells and abnormal CD4+ Th cell subsets in Fancc−/− mice2004173638633870SaadatzadehM. R.Bijangi-VishehsaraeiK.HongP.BergmannH.HanelineL. S.Oxidant hypersensitivity of Fanconi anemia type C-deficient cells is dependent on a
redox-regulated apoptotic pathway200427916168051681210.1074/jbc.M313721200PangQ.ChristiansonT. A.KeebleW.The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality20019851392140110.1182/blood.V98.5.1392ParkS.-J.CicconeS. L. M.BeckB. D.Oxidative stress/damage induces multimerization and interaction of Fanconi anemia proteins2004279293005330059MukhopadhyayS. S.LeungK. S.HicksM. J.HastingsP. J.YoussoufianH.PlonS. E.splon@bcm.tmc.eduDefective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia2006175222523510.1083/jcb.200607061PaganoG.gbpagano@tin.itDeganP.D'IschiaM.Oxidative stress as a multiple effector in Fanconi anaemia clinical phenotype20057529310010.1111/j.1600-0609.2005.00507.xJakobsP. M.SahaayarubanP.SaitoH.Immortalization of four new Fanconi anemia fibroblast cell lines by an improved procedure199622215115710.1007/BF02369905BorgmannK.RöperB.El-AwadyR. A.Indicators of late normal tissue response after radiotherapy for head and neck cancer: fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations200264214115210.1016/S0167-8140(02)00167-6BaeI.FanS.MengQ.BRCA1 induces antioxidant gene expression and resistance to oxidative stress200464217893790910.1158/0008-5472.CAN-04-1119BarzilaiA.RotmanG.ShilohY.yossih@post.tau.ac.ilATM deficiency and oxidative stress: a new dimension of defective response to DNA damage20021132510.1016/S1568-7864(01)00007-6TaniguchiT.Garcia-HigueraI.XuB.Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways2002109445947210.1016/S0092-8674(02)00747-XWardI. M.ChenJ.Chen.junjie@mayo.eduHistone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress200127651477594776210.1074/jbc.M009785200TanakaT.HalickaH. D.HuangX.TraganosF.DarzynkiewiczZ.darzynk@nymc.eduConstitutive histone H2AX phosphorylation and ATM activation, the reporters of DNA damage by endogenous oxidants200651719401945TimmersC.TaniguchiT.HejnaJ.Positional cloning of a novel Fanconi anemia gene, FANCD220017224124810.1016/S1097-2765(01)00172-1JohnstoneP.ReifsteckC.KohlerS.WorlandP.OlsonS.MosesR. E.Fanconi anemia group A and D cell lines respond normally to inhibitors of cell cycle regulation199723637137710.1007/BF02673747KuhnertV.KachnicL.LiL.The role of FANCD2 in determining cellular
resistance to ionizing radiation2007693, supplement 1S594S59510.1016/j.ijrobp.2007.07.1894RidetA.GuilloufC.DuchaudE.Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome199757917221730BurkittK.LjungmanM.ljungman@umich.eduCompromised Fanconi anemia response due to BRCA1 deficiency in cisplatin-sensitive head and neck cancer cell lines2007253113113710.1016/j.canlet.2007.01.017D'AndreaA. D.Cellular function of the Fanconi anemia pathway200171259126010.1038/nm1201-1259aWangX.KennedyR. D.RayK.StuckertP.EllenbergerT.D'AndreaA. D.alan_dandrea@dfci.harvard.eduChk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway20072783098310810.1128/MCB.02357-06MatsushitaN.KitaoH.IshiaiM.A FancD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair200519684184710.1016/j.molcel.2005.08.018MedhurstA. L.LaghmaniEl. H.SteltenpoolJ.Evidence for subcomplexes in the Fanconi anemia pathway200610862072208010.1182/blood-2005-11-008151RogakouE. P.emrog@helix.nih.govNieves-NeiraW.BoonC.PommierY.BonnerW. M.Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 1392000275139390939510.1074/jbc.275.13.9390SedelnikovaO. A.sedelnio@mail.nih.govHorikawaI.RedonC.Delayed kinetics of DNA double-strand break processing in normal and pathological aging2008718910010.1111/j.1474-9726.2007.00354.x